← Back to Search

Mindfulness Training for Hidradenitis Suppurativa

N/A
Recruiting
Led By Hadar Lev-Tov, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Individuals below the age of 18 years old
Adults unable to consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if mindfulness training can improve quality of life for those with HS, a skin condition causing inflammation and pain.

Who is the study for?
This trial is for adults with Hidradenitis Suppurativa (HS) who are registered at the University of Miami Hospital dermatology system. Participants must speak English and be able to consent. It's not for those under 18, pregnant women, prisoners, individuals with active drug addictions, psychosis or suicidal thoughts, or untreated PTSD.
What is being tested?
The study is testing whether a mindfulness training course can improve the quality of life in HS patients compared to an educational course about HS. Patients will learn techniques aimed at reducing stress and improving mental well-being.
What are the potential side effects?
Mindfulness training generally does not have direct physical side effects but may bring up emotional discomfort as participants become more aware of their thoughts and feelings.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I am unable to give consent for myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HS Quality of Life Measure (HiSQOL) Scores
Secondary study objectives
Dermatology Life Quality Index (DLQI) Scores
Five-Facet Mindfulness Questionnaire - Short Form (FFMQ-SF) Scores
Hidradenitis Suppurativa Physician's Global Assessment Scale (HS-PGA) Scores
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Mindfulness Course GroupExperimental Treatment1 Intervention
Participants will participate in the mindfulness course that would last 6 weeks.
Group II: HS Educational Course GroupExperimental Treatment1 Intervention
Participants will participate in the mindfulness course that would last 6 weeks.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
949 Previous Clinical Trials
428,427 Total Patients Enrolled
4 Trials studying Hidradenitis Suppurativa
105 Patients Enrolled for Hidradenitis Suppurativa
Hadar Lev-Tov, MDPrincipal InvestigatorUniversity of Miami
8 Previous Clinical Trials
200 Total Patients Enrolled
4 Trials studying Hidradenitis Suppurativa
105 Patients Enrolled for Hidradenitis Suppurativa

Media Library

Mindfulness Course Clinical Trial Eligibility Overview. Trial Name: NCT05642039 — N/A
Hidradenitis Suppurativa Research Study Groups: Mindfulness Course Group, HS Educational Course Group
Hidradenitis Suppurativa Clinical Trial 2023: Mindfulness Course Highlights & Side Effects. Trial Name: NCT05642039 — N/A
Mindfulness Course 2023 Treatment Timeline for Medical Study. Trial Name: NCT05642039 — N/A
~10 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top